Relaxation of Blood Donor Requirements

The COVID-19 pandemic has caused critical challenges to the U.S. blood supply. Donor centers have experienced a dramatic reduction in donations due to the implementation of social distancing and the cancellation of blood drives. Maintaining an adequate blood supply is vital to public health. As part of the U.S. Food and Drug Administration’s commitment to fight COVID-19, the agency issued guidance for immediate implementation to address the urgent and immediate need for blood and blood products. Learn more by accessing this document.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in